APA (7th ed.) Citation

Gava, F., Catto, L. F. B., Catto, M. B., Morais, A. L., Reis, M. B. F. d., Gonçalves, T. E., . . . Valera, E. T. (2025). CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation. Wiley. https://doi.org/10.1002/pbc.32034

Chicago Style (17th ed.) Citation

Gava, Flavia, Luiz Fernando Bazzo Catto, Marilia Bazzo Catto, Ana Luiza Morais, Maristella Bergamo Francisco dos Reis, Thiago Eleuterio Gonçalves, Luiz Guilherme Darrigo Jr, Carlos Alberto Scrideli, and Elvis Terci Valera. CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation. Wiley, 2025. https://doi.org/10.1002/pbc.32034.

MLA (9th ed.) Citation

Gava, Flavia, et al. CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation. Wiley, 2025. https://doi.org/10.1002/pbc.32034.